Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PMCJ-9 (BCG Connaught strain) Phase III Intravesical Therapy in NMIBC
jRCT2080220126Phase 3
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Sep 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of BCG Connaught in bladder cancer and non-muscle-invasive bladder cancer (NMIBC), sponsored by Nippon Kayaku Co., Ltd.
02
Drugs
BCG Connaught
03
Conditions
bladder cancernon-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on jRCT2080220126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220126.